Combination therapy in mice: What can we learn that may be useful for understanding rheumatoid arthritis?

Springer Seminars in Immunopathology

Volumn 20, Issue 1-2, 1998, Pages 165-180

  Williams, Richard O ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6 ANTIBODY; METHOTREXATE; MONOCLONAL ANTIBODY; OKT 4; ROLIPRAM; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; COMBINATION CHEMOTHERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0031755851     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00832005     Document Type: Review

References (78)

1. Banerjee S, Wei BY, Hillman K, Luthra HS, David CS (1988) Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J Immunol 141 : 1150
2. Benjamin RJ, Waldmann H (1986) Induction of tolerance by monoclonal antibody therapy. Nature 320 : 449
3. Boissier MC, Feng XZ, Carlioz A, Roudier R, Fournier C (1987) Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Ann Rheum Dis 46 : 691
4. Brahn E, Trentham DE (1984) Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis. Cell Immunol 86 : 421
5. Brahn E, Peacock DJ, Banquerigo ML (1991) Suppression of collagen-induced arthritis by combination cyclosporin A and methotrexate therapy. Arthritis Rheum 34 : 1282
6. + T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum 24 : 1370
7. Reference deleted
8. Calabrese LH, Wilke WS, Perkins AD, Tubbs RR (1989) Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjogren's syndrome. Arthritis Rheum 32 : 1453
9. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H (1984) Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312 : 548
10. Cooper SM, Sriram S, Ranges GE (1988) Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol 141 : 1958
11. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B (1980) Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283 : 666
12. Daikh DI, Finck BK, Linsley PS, Hollenbaugh D, Wofsy D (1997) Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol 159 : 3104
13. Doncarli A, Stasiuk LM, Fournier C, Abehsira-Amar O (1997) Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol 27 : 1451
14. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261 : 1328
15. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J, Woody JN (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumour necrosis factor α. Arthritis Rheum 36 : 1681
16. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smollen JS, Leeb B, Breedfeld FC, Macfarlane JD, Bijl H, Woody JN (1994) Treatment with a chimaeric monoclonal antibody to tumour necrosis factor α suppresses disease activity in rheumatoid arthritis: results of a multi-centre, randomised, double blind trial. Lancet 344 : 1105
17. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN (1994) Repeated therapy with a monoclonal antibody to tumour necrosis factor α in patients with rheumatoid arthritis. Lancet 344 : 1125
18. Emery P (1997) Prognosis in inflammatory arthritis: the value of HLA genotyping and the oncological analogy. J Rheumatol 24 : 1436
19. Feldmann M, Brennan FM, Abney ER, Hales A, Chernajovsky Y, Katsikis P, Corcoran A, Haworth C, Cope A, Gibbons D, Chu CQ, Field M, Deleuran B, Williams RO, Maini RN (1994) Are imbalances in cytokine function of importance in the pathogenesis of rheumatoid arthritis? In: Davies ME, Dingle JT (eds) Immunopharmacology of joints and connective tissue. Academic Press, London, pp 119-128
20. Finck BK, Chan B, Wofsy D (1994) Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 94 : 585
21. Finck BK, Linsley PS, Wofsy D (1994) Treatment of murine lupus with CTLA4Ig. Science 265 : 1225
22. Firestein GS, Zvaifler NJ (1990) How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33 : 768
23. Galfre G, Milstein C, Wright B (1979) Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature 277 : 131
24. Genain CP, Roberts T, Davis RL, Nguyen MH, Uccelli A, Faulds D, Li Y, Hedgpeth J, Hauser SL (1995) Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA 92 : 3601
25. Goldschmidt TJ, Holmdahl R (1991) Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol 21 : 1327
26. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30 : 1205
27. Griggs ND, Agersborg SS, Noelle RJ, Ledbetter JA, Linsley PS, Tung KS (1996) The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J Exp Med 183 : 801
28. Holmdahl R, Jansson L, Larsson E, Rubin K, Klareskog L (1986) Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum 29 : 106
29. Holmdahl R, Andersson M, Enander I, Goldschmidt T, Jansson L, Larsson P, Mo J, Nordling C, Klareskog L (1988) Nature of the type II collagen autoimmunity in mice susceptible to collagen-induced arthritis. Int Rev Immunol 4 : 49
30. Holmdahl R, Andersson ME, Goldschmidt TJ, Jansson L, Karlsson M, Malmström V, Mo J (1989) Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity. APMIS 97 : 575
31. Hom JT, Butler LD, Riedl PE, Bendele AM (1988) The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities. Eur J Immunol 18 : 881
32. Horsfall AC, Butler DM, Marinova L, Warden PJ, Williams RO, Maini RN, Feldmann M (1997) Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol 159 : 5687
33. Jabs DA, Kuppers RC, Saboori AM, Burck CL, Enger C, Lee B (1994) Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice. Cell Immunol 154 : 66
34. Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M, Van den Berg WB (1997) Role of interleukin-4 and interleukin-10 in murine collagen- induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 40 : 249
35. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL (1995) Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 95 : 2868
36. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn, KJ, Pearson TC (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381 : 434
37. Maeda T, Saikawa I, Hotokebuchi T, Sugioka Y, Eto M, Murakami Y (1994) Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody. Arthritis Rheum 37 : 406
38. Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M (1995) Monoclonal anti-TNFα antibody as a probe of pathogenesis and therapy of rheumatoid arthritis. Immunol Rev 144 : 195
39. Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M (1997) Low dose methotrexate (MTX) suppresses anti-globulin responses and potentiates efficacy of a chimeric monoclonal anti-TNFα antibody (cA2) given repeatedly in rheumatoid arthritis (RA). Arthritis Rheum 40 [Suppl] : S 126
40. Malfait A-M, Butler DM, Presky DH, Maini RN, Brennan FM, Feldmann M (1998) Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin Exp Immunol 111 : 377
41. Mauri C, Williams RO, Walmsley M, Feldmann M (1996) Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 26 : 1511
42. Mauri C, Chu CQ, Woodrow D, Mori L, Londei M (1997) Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody. J Immunol 159 : 5032
43. Mohan C, Shi Y, Laman JD, Datta SK (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154 : 1470
44. Moreland LW, Heck LW, Koopman WJ (1997) Biologic agents for treating rheumatoid arthritis. Arthritis Rheum 40 : 397
45. Nguyen DT, Eskandai MK, DeForge LE, Raiford CL, Strieter RM, Kunkel SL, Remick DG (1990) Cyclosporin A modulation of tumor necrosis factor gene expression and effects in vitro and in vivo. J Immunol 144 : 3822
46. Noelle RJ (1998) CD40 and its ligand in cell-mediated immunity. Agents Actions [Suppl] 49 : 17
47. O'Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neill EA (1992) FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357 : 692
48. Oliver SJ, Cheng TP, Banquerigo ML, Brahn E (1995) Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF). Cell Immunol 166 : 196
49. Paulus HE, Machleder HI, Levine S, Yu DT, MacDonald NS (1977) Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum 20 : 1249
50. Persson S, Mikulowska A, Narula S, O'Garra A, Holmdahl R (1996) Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 44 : 607
51. Piguet PF, Grau GE, Vesin C, Loetscher H, Gentz R, Lesslauer W (1992) Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77 : 510
52. Qin S, Cobbold S, Tighe H, Benjamin R, Waldmann H (1987) CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol 17 : 1159
53. Ranges GE, Sriram S, Cooper SM (1985) Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 162 : 1105
54. Rep MH, Oosten BW van, Roos MT, Ader HJ, Polman CH, Lier RA van (1997) Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but docs not affect IFN-gamma secreting Th1 cells in humans. J Clin Invest 99 : 2225
55. Ross SE, Williams RO, Mason LJ, Mauri C, Marinova-Mutafchieva L, Malfait A-M, Maini RN, Feldmann M (1997) Suppression of TNF-α expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram. J Immunol 159 : 6253
56. Sheehan KC, Ruddle NH, Schreiber RD (1989) Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 142 : 3884
57. Sommer N, Loschmann PA, Northoff GH, Weller M, Steinbrecher A, Lichtenfels R, Meyermann R, Riethmuller A, Fontana A (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med 1 : 244
58. Strober S, Kotzin B, Field E, Hoppe R, Myers B, Tanay A (1986) Treatment of autoimmune disease with total lymphoid irradiation. Cellular and humoral mechanisms. Ann N Y Acad Sci 475 : 285
59. Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15 : 797
60. Tanaka Y, Otsuka T, Hotokebuchi T, Miyahara H, Nakashima H, Kuga S, Nemoto Y, Niiro H, Niho Y (1996) Effect of IL-10 on collagen-induced arthritis in mice. Inflamm Res 45 : 283
61. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA (1992) Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 89 : 7375
62. Trentham DE (1982) Collagen arthritis as a relevant model for rheumatoid arthritis: evidence pro and con. Arthritis Rheum 25 : 911
63. Trentham DE, Townes AS, Kang AH (1977) Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 146 : 857
64. Van Boxel JA, Pagel SA (1975) Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 293 : 517
65. Waldmann TA (1991) Monoclonal antibodies in diagnosis and therapy. Science 252 : 1657
66. Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, Feldmann M (1996) IL-10 inhibits progression of established collagen-induced arthritis. Arthritis Rheum 39 : 495
67. Webb LM, Walmsley MJ, Feldmann M (1996) Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 26 : 2320
68. Weyand CM, Hicok KC, Conn DL, Goronzy JJ (1992) The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117 : 801
69. Wiederrecht G, Lam E, Hung S, Martin M, Sigal N (1993) The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci 696 : 9
70. Williams RO, Feldmann M, Maini RN (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89 : 9784
71. Williams RO, Mason IJ, Feldmann M, Maini RN (1994) Synergy between anti-CD4 and anti-TNF in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci USA 91 : 2762
72. Williams RO, Ghrayeb J, Feldmann M, Maini RN (1995) Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology 84 : 433
73. Williams RO, Mauri C, Mason LJ, Marinova-Mutafchieva L, Ross SE, Feldmann M, Maini RN (1998) Therapeutic actions of cyclosporin and anti-TNFα in collagen-induced arthritis and effect of combination therapy. Arthritis Rheum (in press)
74. Wooley PH, Luthra HS, Lafuse WP, Huse A, Stuart JM, David CS (1985) Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera. J Immunol 134 : 2366
75. Yocum DE (1996) Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheum Dis Clin North Am 22 : 133
76. Yoo TJ, Kim SY, Stuart JM, Floyd RA, Olson GA, Cremer MA, Kang AH (1988) Induction of arthritis in monkeys hy immunization with type II collagen. J Exp Med 168 : 777
77. Yoshino S, Cleland LG (1992) Depletion of α/β T cells by a monoclonal antibody against the α/β T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats. J Exp Med 175 : 907
78. Yoshino S, Cleland LG, Mayrhofer G (1991) Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the alpha/beta T cell antigen receptor. Arthritis Rheum 34 : 1039